This review examines whether ghrelin's changes in disease states (inflammation, cardiovascular, GI disorders) represent active disease participation or passive biomarker changes — concluding it's likely an active player with therapeutic implications.
Key findingGhrelin changes in various disease states (cardiovascular, inflammatory, GI, metabolic) likely represent active physiological responses with functiona
What the researchers found
Ghrelin changes in various disease states (cardiovascular, inflammatory, GI, metabolic) likely represent active physiological responses with functional consequences, not passive biomarker changes — supporting therapeutic ghrelin modulation in disease.
Why it matters
Relevant for ghrp, hormone-optimization, inflammation, cardiovascular.
How the study worked
review study on ghrp, hormone-optimization.
What this study cannot tell us
See abstract.
How to read the evidence
moderate evidence.
When this study was published
Published in 2005.
The bigger picture
Advances peptide research with clinical implications.
Questions still open
- Further research needed.
- Clinical translation to evaluate.
Common questions
What was studied?
What was found?
Read the original research
Ghrelin, the same peptide for different functions: player or bystander?
Vitamins and hormones, 71, 405-32
Citation
Lago, Francisca; Gonzalez-Juanatey, José Ramón; Casanueva, Felipe F; Gómez-Reino, Juan; Dieguez, Carlos; Gualillo, Oreste. (2005). Ghrelin, the same peptide for different functions: player or bystander?. Vitamins and hormones, 71, 405-32.